Kansas gets mixed reviews when it comes to implementing policies and passing legislation to reduce cancer incidence and death from tobacco use, according to the latest edition of “How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality.” The American Cancer Society Cancer Action Network released the report today.
Missouri falls short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer. According to the latest edition of “How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality,” Missouri measured up to policy recommendations in just two of the nine issue areas. The American Cancer Society Cancer Action Network released the report today.
FOR MORE INFORMATION, CONTACT:
Deb Knuth
American Cancer Society Cancer Action Network
Phone: 701-314-4880
Email: [email protected]
Minnesota gets mixed reviews when it comes to implementing legislation to prevent and reduce suffering and death from cancer according to the latest edition of How Do You Measure Up?.
Iowa falls short when it comes to implementing legislation to prevent and reduce suffering and death from cancer according to the latest edition of the American Cancer Society Cancer Action Network’s How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, released today.
TRENTON, NJ – August 9, 2018 – New Jersey is making progress when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer.
Delaware Making Progress on Cancer-Fighting Public Policies
Must Do Better Addressing Pain and Opioid Issues
ALBANY, NY – August 9, 2018 – New York State must act when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer.
The Center for Medicare and Medicaid Services (CMS) issued guidance last night giving Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs, effective January 1, 2019.